Phase 3 randomized COMMODORE 1 trial: crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria - Scheinberg, Phillip; Clé, Diego Villa; Kim, Jin Seok; Nur, Erfan; Yenerel, Mustafa N.; Barcellini, Wilma; Bonito, Debora; Giai, Valentina; Hus, Marek; Lee, YooJin; Lekue, Cristina Barrenetxea; Panse, Jens; et al. (American Journal of Hematology, 2024)